Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...

Short GRFS slightly under 7.02, target n/a, stop loss @ 7.04 Check the time stamp on this data. Updated AI-Generated Signals ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...

UEFA has today announced that Unilever, a global leader in consumer goods, has become an official global partner of UEFA ...

For decades, Grifols grew rich from an empire built on blood. Founded by a plucky scientist and his two sons in the years after the Spanish Civil War, the company made a series of breakthroughs that ...

"We urge the CNMV to consider the benefits to all Grifols shareholders from improved disclosure," Mason Capital said. The CNMV declined to comment about the letter. Grifols shares were down around ...

MADRID (Reuters) - U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical ...

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...